Genetics consortiums can offer views facilitating best practice in Alzheimer's disease

Comment

S Lovestone. BMJ. 1998.

. 1998 Aug 15;317(7156):471.

doi: 10.1136/bmj.317.7156.471.

No abstract available

Comment on

Meeting the challenge of genetic advance.
Gill M, Richards T. Gill M, et al. BMJ. 1998 Feb 21;316(7131):570. doi: 10.1136/bmj.316.7131.570. BMJ. 1998. PMID: 9518896 Free PMC article. No abstract available.
The new genetics in clinical practice.
Bell J. Bell J. BMJ. 1998 Feb 21;316(7131):618-20. doi: 10.1136/bmj.316.7131.618. BMJ. 1998. PMID: 9518921 Free PMC article. Review. No abstract available.
The new genetics. Psychological responses to genetic testing.
Marteau TM, Croyle RT. Marteau TM, et al. BMJ. 1998 Feb 28;316(7132):693-6. doi: 10.1136/bmj.316.7132.693. BMJ. 1998. PMID: 9522800 Free PMC article. Review. No abstract available.

1. Bell J. The new genetics in clinical practice. BMJ. 1998;316:618–620. . (21 February.) - PMC - PubMed
1. Pokorski RJ. A test for the insurance industry. Nature. 1998;391:835–836. - PubMed
1. Gill M, Richards T. Meeting the challenge of genetic advance. BMJ. 1998;316:570. . (21 February.) - PMC - PubMed
1. Lovestone S, Wilcock G, Rossor M, Cayton H, Ragan I. Apolipoprotein E genotyping in Alzheimer’s disease. Lancet. 1996;347:1775–1776. - PubMed
1. Marteau TM, Croyle RT. Psychological responses to genetic testing. BMJ. 1998;316:693–696. . (28 February.) - PMC - PubMed